Sort
23,748 grants matching “melanoma”
Controlling the flux of sphingosine-1-phosphate in vivo
$720,889Kevin R Lynch · University Of Virginia · R01 · FY2019 · AI
Advancing the translatability of mouse models for cancer immunotherapy
$720,801Rosemary J Akhurst · University Of California, San Francisco · R01 · FY2020 · CA
Tumor Growth and Microenvironment Influence T Cell Tolerance to Tumor Antigens
$720,716Arthur Hurwitz · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Nitro-Fatty Acids and Cardiovascular Disease
$720,438Yuqing E Chen · University Of Michigan At Ann Arbor · R01 · FY2025 · HL
Nitro-Fatty Acids and Cardiovascular Disease
$720,438Yuqing E Chen · University Of Michigan At Ann Arbor · R01 · FY2023 · HL
Nitro-Fatty Acids and Cardiovascular Disease
$720,438Yuqing E Chen · University Of Michigan At Ann Arbor · R01 · FY2022 · HL
Cellular Interactions with Thrombospondin
$720,215David D Roberts · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA
TLR5 enhancement of liver-directed radiotherapy plus immune checkpoint blockade against irradiated liver metastasis and abscopal tumors
$720,023Craig M. Brackett · Roswell Park Cancer Institute Corp · R01 · FY2023 · CA
Synthetic introns for selective targeting of RNA splicing factor-mutant leukemia
$719,414Robert K Bradley · Fred Hutchinson Cancer Center · R01 · FY2025 · CA
(PQ1) Lipid Metabolism, Inflammation, and T cell Dysfunction in HIV-associated Cancer
$718,958Brinda Emu · Yale University · R01 · FY2017 · CA
Activation of the DNA-PK-dependent antiviral response as a novel cancer immunotherapy
$718,598Daniel B Stetson · University Of Washington · R01 · FY2022 · CA
Understanding biomarkers of cognitive decline in Lewy body diseases
$718,338Alice S Chen-Plotkin · University Of Pennsylvania · R37 · FY2025 · NS
In vivo imaging of single circulating cells
$717,674Lihong Wang · California Institute Of Technology · R01 · FY2017 · CA
THE FRAMINGHAM SCHOOL STUDY OF NEVI IN CHILDREN SONIC II
$717,503Allan C Halpern · Sloan-Kettering Inst Can Research · R01 · FY2011 · AR
DISSECTING THE DASATINIB-OME AND OPTIMIZING THERAPY DELIVERY TO ADDRESS CELLULAR PLASTICITY AND THERAPY RESISTANCE IN ACRAL MELANOMA
$716,062The Johns Hopkins University · · FY2024 · Defense Health Agency
Reverse Sensitivity Analysis for Identifying Predictive Proteomics Signatures of Cancer
$715,682H. Steven Wiley · Battelle Pacific Northwest Laboratories · U01 · FY2020 · CA
Mutational and Functional Analysis of Sporadic Malignant Melanoma
$715,651Yardena Samuels · National Human Genome Research Institute · ZIA · FY2013 · HG
PSMA-Dye Surgical Margin Imaging During Prostatectomy
$715,221Spectros Corporation · R44 · FY2005 · CA
ISIC-REPO; ISICâ¯Skin Imagingâ¯Repository Enhancements for Promoting Interoperability and Utilization
$715,146Allan C Halpern · Sloan-Kettering Inst Can Research · U24 · FY2024 · CA
Structural Biology of GTPase Activating Proteins
$715,059Robert Byrd · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Tissue Array Research Program
$714,730Stephen Hewitt · Division Of Basic Sciences - Nci · ZIC · FY2011 · CA
Early development of small molecule dendritic cell immunopotentiators for the treatment of solid tumors
$714,132Sumit K Chanda · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2020 · CA
Personal tumor neoantigens for immunity against chronic lymphocytic leukemia
$714,052Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2024 · CA
Tumor gene expression in vitro and in vivo
$714,031Douglas R. Lowy · Basic Sciences · Z01 · FY2007 · CA
PD-1 blockade with cryoablation and dendritic vaccine to treat lymphoma
$713,488Yi Lin · Mayo Clinic Rochester · R01 · FY2021 · CA